Center for Molecular Orthopedics

The Center for Molecular Orthopaedics is a specialized medical facility based in Düsseldorf, Germany, pioneered by Dr. Peter Wehling. The center is globally recognized for developing and administering Orthokine (marketed as Regenokine in the United States), an autologous conditioned serum therapy used to treat osteoarthritis and spinal disorders. This treatment involves processing a patient's own blood to produce a high concentration of anti-inflammatory proteins, specifically interleukin-1 receptor antagonists. The center focuses on non-surgical, biological approaches to musculoskeletal conditions and has gained significant fame for treating numerous high-profile professional athletes. Their work represents a leading edge in regenerative medicine, bridging the gap between molecular biology and clinical orthopedic practice.